These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 22451019)
1. The G protein-coupled oestrogen receptor 1 agonist G-1 disrupts endothelial cell microtubule structure in a receptor-independent manner. Holm A; Grände PO; Ludueña RF; Olde B; Prasad V; Leeb-Lundberg LM; Nilsson BO Mol Cell Biochem; 2012 Jul; 366(1-2):239-49. PubMed ID: 22451019 [TBL] [Abstract][Full Text] [Related]
2. The GPER1 agonist G-1 attenuates endothelial cell proliferation by inhibiting DNA synthesis and accumulating cells in the S and G2 phases of the cell cycle. Holm A; Baldetorp B; Olde B; Leeb-Lundberg LM; Nilsson BO J Vasc Res; 2011; 48(4):327-35. PubMed ID: 21273787 [TBL] [Abstract][Full Text] [Related]
3. G-1 Inhibits Breast Cancer Cell Growth via Targeting Colchicine-Binding Site of Tubulin to Interfere with Microtubule Assembly. Lv X; He C; Huang C; Hua G; Wang Z; Remmenga SW; Rodabough KJ; Karpf AR; Dong J; Davis JS; Wang C Mol Cancer Ther; 2017 Jun; 16(6):1080-1091. PubMed ID: 28258163 [TBL] [Abstract][Full Text] [Related]
5. The G protein-coupled oestrogen receptor, GPER1, mediates direct anti-inflammatory effects of oestrogens in human cholinergic neurones from the nucleus basalis of Meynert. Sarchielli E; Guarnieri G; Idrizaj E; Squecco R; Mello T; Comeglio P; Gallina P; Maggi M; Vannelli GB; Morelli A J Neuroendocrinol; 2020 Mar; 32(3):e12837. PubMed ID: 32077170 [TBL] [Abstract][Full Text] [Related]
6. Ligand-Independent G Protein-Coupled Estrogen Receptor/G Protein-Coupled Receptor 30 Activity: Lack of Receptor-Dependent Effects of G-1 and 17 Tutzauer J; Gonzalez de Valdivia E; Swärd K; Alexandrakis Eilard I; Broselid S; Kahn R; Olde B; Leeb-Lundberg LMF Mol Pharmacol; 2021 Sep; 100(3):271-282. PubMed ID: 34330822 [TBL] [Abstract][Full Text] [Related]
7. G protein-coupled receptor 30 ligand G-1 increases aryl hydrocarbon receptor signalling by inhibition of tubulin assembly and cell cycle arrest in human MCF-7 cells. Tarnow P; Tralau T; Luch A Arch Toxicol; 2016 Aug; 90(8):1939-48. PubMed ID: 26475489 [TBL] [Abstract][Full Text] [Related]
9. 4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP) Targets Estrogen Receptor β, to Evoke the Resistance of Human Breast Cancer MCF-7 Cells to G-1, an Agonist for G Protein-Coupled Estrogen Receptor 1. Hirao-Suzuki M; Nagase K; Suemori T; Tsutsumi K; Shigemori E; Tanaka M; Takiguchi M; Sugihara N; Yoshihara S; Takeda S Biol Pharm Bull; 2021; 44(10):1524-1529. PubMed ID: 34602561 [TBL] [Abstract][Full Text] [Related]
10. G protein-coupled estrogen receptor 1 agonist G-1 induces cell cycle arrest in the mitotic phase, leading to apoptosis in endometriosis. Mori T; Ito F; Matsushima H; Takaoka O; Tanaka Y; Koshiba A; Kusuki I; Kitawaki J Fertil Steril; 2015 May; 103(5):1228-35.e1. PubMed ID: 25724739 [TBL] [Abstract][Full Text] [Related]
11. Sulforaphane suppresses angiogenesis and disrupts endothelial mitotic progression and microtubule polymerization. Jackson SJ; Singletary KW; Venema RC Vascul Pharmacol; 2007 Feb; 46(2):77-84. PubMed ID: 16938492 [TBL] [Abstract][Full Text] [Related]
12. Cardioprotective role of G-Protein Coupled Estrogen Receptor 1 (GPER1). Koganti S Mol Membr Biol; 2015; 32(2):35-8. PubMed ID: 25922871 [TBL] [Abstract][Full Text] [Related]
13. G protein-coupled estrogen receptor1 (GPER1) may mediate Rho-kinase (ROCK-2) up-regulation in coronary endothelial cells. Kurt AH; Tiftik RN; Un I; Ulker S; Buyukafsar K Endocr Regul; 2013 Apr; 47(2):75-84. PubMed ID: 23641788 [TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic and vascular disrupting effects of C9, a new microtubule-depolymerizing agent. Ren X; Dai M; Lin LP; Li PK; Ding J Br J Pharmacol; 2009 Apr; 156(8):1228-38. PubMed ID: 19302593 [TBL] [Abstract][Full Text] [Related]
15. Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2.Lewis female rat. Lindsey SH; Carver KA; Prossnitz ER; Chappell MC J Cardiovasc Pharmacol; 2011 May; 57(5):598-603. PubMed ID: 21326105 [TBL] [Abstract][Full Text] [Related]
16. The Glycolytic Enzyme PFKFB3 Is Involved in Estrogen-Mediated Angiogenesis via GPER1. Trenti A; Tedesco S; Boscaro C; Ferri N; Cignarella A; Trevisi L; Bolego C J Pharmacol Exp Ther; 2017 Jun; 361(3):398-407. PubMed ID: 28348059 [TBL] [Abstract][Full Text] [Related]
17. G-protein coupled receptor 30 (GPR30): a novel regulator of endothelial inflammation. Chakrabarti S; Davidge ST PLoS One; 2012; 7(12):e52357. PubMed ID: 23285008 [TBL] [Abstract][Full Text] [Related]
18. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines. Skrzypczak M; Schüler S; Lattrich C; Ignatov A; Ortmann O; Treeck O Steroids; 2013 Nov; 78(11):1087-91. PubMed ID: 23921077 [TBL] [Abstract][Full Text] [Related]
19. Stimulation of oestrogen receptor-expressing endothelial cells with oestrogen reduces proliferation of cocultured vascular smooth muscle cells. Odenlund M; Ekblad E; Nilsson BO Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):245-8. PubMed ID: 18290870 [TBL] [Abstract][Full Text] [Related]
20. G protein-coupled estrogen receptor 1 negatively regulates the proliferation of mouse-derived neural stem/progenitor cells via extracellular signal-regulated kinase pathway. Zhong J; Ge HF; Zhang C; Chen JY; Li HH; Fang XY; Tan L; Liu X; Jia ZC; Feng H; Hu R Brain Res; 2019 Jul; 1714():158-165. PubMed ID: 30797747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]